| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690693 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
Patients with large cell NECC have better outcomes than patients with other subtypes of NECC. In early-stage node-negative NECC, chemoradiation yields better EFS than surgery. Most patients with NECC, even those with no evidence of nodal disease at diagnosis, rapidly develop widespread hematogenous metastases and die of their disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Shane R. Stecklein, Anuja Jhingran, Jennifer Burzawa, Preetha Ramalingam, Ann H. Klopp, Patricia J. Eifel, Michael Frumovitz,